Dossier
XFG subvariant
Coverage of XFG subvariant in the Nexus archive.
- FDA advisers to weigh updated COVID vaccine targeting XFG subvariant
The FDA's Vaccines and Related Biological Products Advisory Committee (VRBPAC) will meet to discuss updating the COVID-19 vaccine to target the XFG subvariant for the 2026-2027 respiratory season. The meeting aims to determine whether current vaccines should be modified to address this emerging variant.